- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
-
News
-
Adding Breast Milk Ingredient to Formula Could Prevent Deadly Intestinal Problem in Premature Babies
-
Children's Holds Groundbreaking Ceremony for Expansion to New South Fayette Location
-
Child Neurodevelopmental and Mental Health Disabilities on the Rise, Study Finds
News Releases
-
Research
Cystic Fibrosis Heart Rate and Exercise Study
Simplifying Prognostic Testing in Cystic Fibrosis: Correlation of Heart Rate Recovery After Sub-maximal Aerobic Exercise with Maximal Exercise Testing Results
Protocol Description
This study compares two testing regimens for cystic fibrosis patients to determine whether a shorter, easier exercise test called STEP-30, can be as effective as the traditional maximal exercise test. By determining the point at which the heart and lungs become physically stressed during exercise, maximal exercise tests are often used to help to predict how healthy patients with cystic fibrosis will be in the future. People with cystic fibrosis who perform well on maximal exercise tests tend to be less sick in the years after the test than people who do not perform as well.
Eligibility Criteria
Children and young adults of both genders who have already been scheduled for the maximal exercise test are eligible to participate in this study.
Males and Females: Age 8 and older
Requirements
Prior to engaging in the maximal exercise test, participants will do the STEP-30 exercise. The STEP-30 exercise requires that the child step on and off a stair 30 times a minute for 3 minutes. Heart rate and oxygen saturation are monitored before during and after the test.
Visits: 1
Duration: Not applicable
Status: Open for Enrollment
Primary Investigator(s)
Sara Cohen
David M. Orenstein, MD
David M. Orenstein, MD
Contact Information
For information, please contact:
Elizabeth Hartigan, MPH, RN
1-877-296-9026
Last Update
July 21, 2012
July 21, 2012
